|
|
Substance Name: Lithium carbonate [USAN:USP:JAN]
RN: 554-13-2
UNII: 2BMD2GNA4V
InChIKey: XGZVUEUWXADBQD-UHFFFAOYSA-L
Note
- A lithium salt, classified as a mood-stabilizing agent. Lithium ion alters the metabolism of BIOGENIC MONOAMINES in the CENTRAL NERVOUS SYSTEM, and affects multiple neurotransmission systems.
Molecular Formula
- C-H2-O3.2Li
Molecular Weight
- 73.89
- All
- Classifications
- Links to Resources
- Names & Synonyms
- Registry Numbers
- Formulas
- Structure Descriptors
- Toxicity
Classification Codes
- Antidepressive Agents
- Antimanic
- Antimanic Agents
- Central Nervous System Agents
- Central Nervous System Depressants
- Drug / Therapeutic Agent
- Enzyme Inhibitors
- Human Data
- Mutation Data
- Psychotropic Drugs
- Reproductive Effect
- Tranquilizing Agents
- Tumor Data
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Regulatory Agencies (Superlist Locators)
Other Resources (Internet Locators)
Search for this InChIKey on the Web
Names and Synonyms
Name of Substance
- Lithium carbonate
- Lithium carbonate [USAN:USP:JAN]
MeSH Heading
- Lithium carbonate
Synonyms
- Camcolit
- Candamide
- Carbolith
- Carbolitium
- Carbonic acid lithium salt
- Carbonic acid lithium salt (Li2CO3)
- Carbonic acid, dilithium salt
- CCRIS 3153
- Ceglution
- CP 15467-61
- CP-15,467-61
- CP-15467-61
- Dilithium carbonate
- EC 209-062-5
- EINECS 209-062-5
- Eskalith
- Eskalith CR
- Eutimin
- HSDB 3351
- Hypnorex
- Limas
- Liskonum
- Litard
- Lithane
- Lithea
- Lithicarb
- Lithinate
- Lithionate
- Lithium carbonate
- Lithium carbonate (Li2CO3)
- Lithium carbonicum
- Lithium Phasal
- Lithizine
- Litho-Carb
- Lithobid
- Lithonate
- Lithotabs
- Liticar
- Manialith
- Maniprex
- Micalith
- Neurolepsin
- NSC-16895
- Pfi-lithium
- Pfl-Lithium
- Phasal
- Plenur
- Priadel
- Quilonorm
- Quilonum retard
- Teralithe
- Teralithe [French]
- UNII-2BMD2GNA4V
Systematic Names
- Carbonic acid, dilithium salt
- Carbonic acid, lithium salt (1:2)
- Lithium carbonate
- Lithium carbonate (2:1)
Superlist Name
- Lithium carbonate
Registry Numbers
CAS Registry Number
- 554-13-2
FDA UNII
- 2BMD2GNA4V
Other Registry Numbers
- 12767-19-0
- 1312765-65-3
- 2006273-00-1
- 216964-61-3
Related Registry Number
- 10377-37-4 (mono-lithium salt)
System Generated Number
- 0000554132
Molecular Formulas
Molecular Formula
- C-H2-O3.2Li
Molecular Formula Fragments
- C-H2-O3
- COMPONENT
- Li
Structure Descriptors
InChI
InChI=1S/CH2O3.2Li/c2-1(3)4;;/h(H2,2,3,4);;/q;2*+1/p-2InChIKey
XGZVUEUWXADBQD-UHFFFAOYSA-LSmiles
[Li+].[Li+].[O-]C(=O)Toxicity
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LD50 | oral | 500mg/kg (500mg/kg) | "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 436, 1972. | |
human | TDLo | oral | 4111mg/kg (4111mg/kg) | GASTROINTESTINAL: OTHER CHANGES BEHAVIORAL: TREMOR BEHAVIORAL: MUSCLE WEAKNESS | New England Journal of Medicine. Vol. 287, Pg. 867, 1972. |
man | TDLo | oral | 8mg/kg (8mg/kg) | GASTROINTESTINAL: NAUSEA OR VOMITING SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" | American Journal of Psychiatry. Vol. 141, Pg. 909, 1984. |
man | TDLo | oral | 54mg/kg (54mg/kg) | BEHAVIORAL: SLEEP BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS" | New Zealand Medical Journal. Vol. 97, Pg. 23, 1984. |
man | TDLo | oral | 1080mg/kg/13W (1080mg/kg) | SKIN AND APPENDAGES (SKIN): "DERMATITIS, ALLERGIC: AFTER SYSTEMIC EXPOSURE" | Journal of Clinical Psychiatry. Vol. 47, Pg. 330, 1986. |
man | TDLo | oral | 25gm/kg/4Y-I (25000mg/kg) | BEHAVIORAL: TREMOR SENSE ORGANS AND SPECIAL SENSES: MIOSIS (PUPILLARY CONSTRICTION): EYE | Journal of Clinical Psychiatry. Vol. 46, Pg. 292, 1985. |
mouse | LD50 | intraperitoneal | 236mg/kg (236mg/kg) | BEHAVIORAL: ATAXIA BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: EXCITEMENT | Kiso to Rinsho. Clinical Report. Vol. 7, Pg. 1273, 1973. |
mouse | LD50 | intravenous | 497mg/kg (497mg/kg) | LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) | Kiso to Rinsho. Clinical Report. Vol. 7, Pg. 1273, 1973. |
mouse | LD50 | oral | 531mg/kg (531mg/kg) | Russian Pharmacology and Toxicology Vol. 33, Pg. 266, 1970. | |
mouse | LD50 | subcutaneous | 413mg/kg (413mg/kg) | Russian Pharmacology and Toxicology Vol. 33, Pg. 266, 1970. | |
rat | LD50 | intraperitoneal | 156mg/kg (156mg/kg) | GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Kiso to Rinsho. Clinical Report. Vol. 7, Pg. 1273, 1973. |
rat | LD50 | intravenous | 241mg/kg (241mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Kiso to Rinsho. Clinical Report. Vol. 7, Pg. 1273, 1973. |
rat | LD50 | oral | 525mg/kg (525mg/kg) | LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" | Kiso to Rinsho. Clinical Report. Vol. 7, Pg. 1273, 1973. |
rat | LD50 | subcutaneous | 434mg/kg (434mg/kg) | SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION SKIN AND APPENDAGES (SKIN): HAIR: OTHER | Kiso to Rinsho. Clinical Report. Vol. 7, Pg. 1273, 1973. |
women | TDLo | oral | 120mg/kg/10D- (120mg/kg) | BEHAVIORAL: EXCITEMENT | Journal of Clinical Psychiatry. Vol. 48, Pg. 81, 1987. |
women | TDLo | oral | 612mg/kg/44D- (612mg/kg) | SKIN AND APPENDAGES (SKIN): "DERMATITIS, ALLERGIC: AFTER SYSTEMIC EXPOSURE" BEHAVIORAL: SLEEP | American Journal of Psychiatry. Vol. 152, Pg. 956, 1995. |
women | TDLo | oral | 8760mg/kg/2Y- (8760mg/kg) | ENDOCRINE: EVIDENCE OF THYROID HYPERFUNCTION ENDOCRINE: THYROID WEIGHT (GOITER) | American Journal of Medicine. Vol. 99, Pg. 575, 1995. |
women | TDLo | oral | 36500mg/kg/10 (36500mg/kg) | ENDOCRINE: DIABETES INSIPIDUS (NEPHROGENIC OR CNS) KIDNEY, URETER, AND BLADDER: URINE VOLUME INCREASED KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)" | Annales de Medecine Interne. Vol. 148, Pg. 284, 1997. |
women | TDLo | unreported | 556mg/kg/32D (556mg/kg) | BEHAVIORAL: TOXIC PSYCHOSIS | JAMA, Journal of the American Medical Association. Vol. 213, Pg. 865, 1970. |